MedRhythms Inc is a pioneering company based in Allston, MA that combines music and technology to develop next-generation neurotherapeutics aimed at improving walking and mobility for individuals with neurologic injuries or diseases. With a focus on evidence-based interventions such as Rhythmic Auditory Stimulation (RAS), their proprietary technology platform utilizes sensors, software, and music to target neural circuitry and promote clinically meaningful changes in functional outcomes. MedRhythms is dedicated to positively impacting the lives of millions of people worldwide who suffer from walking deficits, aiming to rewrite the story of walking disability through transformative and innovative therapeutics.
Founded by board-certified Neurologic Music Therapist Brian Harris, MedRhythms has over 30 years of academic research supporting the potential of RAS to improve walking impairments. With a team of passionate leaders and clinicians who have delivered over 30,000 hours of direct patient care, the company is committed to leveraging technology as a scalable modality to meet the growing demand for neurologic gait disorder treatments. Through collaborations with Universal Music Group, MedRhythms aims to provide patients with therapy via music they know and enjoy, offering a diverse and culturally rich collection of music on their world's first prescription music platform.
Generated from the website